[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 18.206.12.79. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Article
June 1990

Treatment Selection Considerations for the Hypertensive Diabetic Patient: A. Richard Christlieb, MD

Author Affiliations

From the Epidemiology and Genetics Section and the Joslin Clinic Division of the Joslin Diabetes Center, Department of Medicine, New England Deaconess Hospital, Brigham and Women's Hospital, Harvard Medical School, Boston, Mass.

Arch Intern Med. 1990;150(6):1167-1174. doi:10.1001/archinte.1990.00390180011002
Abstract

• Hypertension occurs with twice the frequency in the diabetic population as compared with the general nondiabetic population. Treatment of hypertension in diabetics can be complicated by diabetic complications and the potential for adverse effects from selected antihypertensive drugs. A rational approach to antihypertensive therapy in diabetics with or without concurrent diabetic complications incorporates a "stepped" approach to therapy that includes alternative step 1 agents (eg, angiotensinconverting enzyme inhibitors and calcium channel blockers) rather than traditional agents (eg, diuretics and β-blockers). Evolving evidence with angiotensin-converting enzyme inhibitors reveals that they do not exacerbate complications of diabetes mellitus and also may arrest or slow the progression of diabetic nephropathy. Treatment algorithms for a stepped approach to the management of the hypertensive diabetic patient are proposed.

(Arch Intern Med. 1990;150:1167-1174)

×